Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
●Choosing Wisely Canada: Don't initiate erythropoiesis-stimulating agents (ESAs) in chronic kidney disease (CKD) patients with hemoglobin levels greater than or equal to 100 g/L without symptoms of anemia (2021)
●Kidney Health Australia-Caring for Australasians with Renal Impairment (KHA-CARI): Guideline ─ Biochemical and haematological targets: Haemoglobin concentrations in patients using erythropoietin stimulating agents (2011)
●[In English] Japanese Society for Dialysis Therapy (JSDT): Guidelines for renal anemia in chronic kidney disease, 2015 (published 2017)
●[In Japanese] JSDT: Guidelines for the treatment of renal anemia in patients with chronic kidney disease, 2015 (published 2016)
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟